Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08QIR
|
||||
| Former ID |
DIB004693
|
||||
| Drug Name |
H2S-releasing latanoprost
|
||||
| Synonyms |
ACS-67; H2S-releasing latanoprost (ocular disease); H2S-releasing latanoprost (ocular disease), CTG Pharma
|
||||
| Indication | Ocular disease [ICD10:H00-H59] | Investigative | [543781] | ||
| Company |
CTG Pharma Srl
|
||||
| Canonical SMILES |
c1c(=S)ssc1c1ccc(OC(=O)CCC/C=C\C[C@@H]2[C@H]([C@@H](C[C<br />@@H]2O)O)CC[C@H](CCc2ccccc2)O)cc1
|
||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin F2-alpha receptor | Target Info | Modulator | [543781] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.